0.25Open0.25Pre Close0 Volume68 Open Interest2.50Strike Price0.00Turnover457.83%IV64.67%PremiumNov 15, 2024Expiry Date0.00Intrinsic Value100Multiplier9DDays to Expiry0.25Extrinsic Value100Contract SizeAmericanOptions Type0.4164Delta0.3288Gamma6.68Leverage Ratio-0.0270Theta0.0001Rho2.78Eff Leverage0.0010Vega
Trinity Biotech Stock Discussion
📊⚡️📊
Trinity Biotech Announces Strategic Investment in Novus Diagnostics to Advance Rapid Sepsis Testing Platform
Trinity Biotech Announces Positive Pre-Pivotal Trial Results for Its Next-Generation Continuous Glucose Monitor Technology
Trinity Biotech Announces Positive Pre-Pivotal Trial Results for Its Next-Generation Continuous Glucose Monitor Technology
DUBLIN, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (NASDAQ:TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced the successful completion of its first pre-pivotal clinical trial in Europe for its next-generation continuous glucos...
No comment yet